{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T09:43:24Z","timestamp":1794390204896,"version":"4.9.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vaccine.2024.126479","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T08:09:27Z","timestamp":1730448567000},"page":"126479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"P1","title":["Burden of Lassa fever disease in pregnant women and children and options for prevention"],"prefix":"10.1016","volume":"43","author":[{"given":"Manu","family":"Chaudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L.","family":"Cutland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Bonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen S.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Stergachis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delese Mimi","family":"Darko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanca","family":"Sevene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Fairlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcie","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor M.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126479_bb0005","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4269\/ajtmh.1970.19.670","article-title":"Lassa fever, a new virus disease of man from West Africa. I. clinical description and pathological findings","volume":"19","author":"Frame","year":"1970","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.126479_bb0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41579-022-00789-8","article-title":"Lassa fever - the road ahead","volume":"21","author":"Garry","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2024.126479_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002748","article-title":"Lassa fever in post-conflict sierra leone","volume":"8","author":"Shaffer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0020","first-page":"1","article-title":"Lassa fever in west African sub-region: an overview","volume":"44","author":"Ogbu","year":"2007","journal-title":"J Vector Borne Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0025","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2024.126479_bb0030","series-title":"Emergence and control of rodent-borne viral diseases","first-page":"177","article-title":"Lassa fever","author":"McCormick","year":"1999"},{"key":"10.1016\/j.vaccine.2024.126479_bb0035","author":"Nigeria Centre for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2024.126479_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008811","article-title":"Bridging the gap: using reservoir ecology and human serosurveys to estimate Lassa virus spillover in West Africa","volume":"17","author":"Basinski","year":"2021","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2024.126479_bb0045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/trstmh\/traa011","article-title":"Lassa fever in pregnancy: a systematic review and meta-analysis","volume":"114","author":"Kayem","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.126479_bb0050","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4269\/ajtmh.1987.36.408","article-title":"Pediatric Lassa fever: a review of 33 Liberian cases","volume":"36","author":"Monson","year":"1987","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.126479_bb0055","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.297.6648.584","article-title":"A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy","volume":"297","author":"Price","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2024.126479_bb0060","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4269\/ajtmh.20-0773","article-title":"Lassa fever among children in Eastern Province, Sierra Leone: a 7-year retrospective analysis (2012-2018)","volume":"104","author":"Samuels","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.126479_bb0065","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3201\/eid2506.181035","article-title":"Epidemiologic and clinical features of Lassa fever outbreak in Nigeria, January 1-may 6, 2018","volume":"25","author":"Ilori","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijid.2019.07.015","article-title":"Ribavirin for the treatment of Lassa fever: a systematic review and meta-analysis","volume":"87","author":"Eberhardt","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/v16020266","article-title":"The importance of Lassa fever and its disease management in West Africa","volume":"16","author":"Reyna","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.126479_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2010.02.465","article-title":"Prevalence and presentation of Lassa fever in Nigerian children","volume":"14","author":"Akpede","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0085","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.1128\/JVI.00896-06","article-title":"Identification of protective Lassa virus epitopes that are restricted by HLA-A2","volume":"80","author":"Botten","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126479_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000836","article-title":"T cell-dependence of Lassa fever pathogenesis","volume":"6","author":"Flatz","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2024.126479_bb0095","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0140-6736(79)90659-7","article-title":"Protection of rhesus monkeys from Lassa virus by immunisation with closely related arenavirus","volume":"2","author":"Kiley","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.126479_bb0100","first-page":"94","article-title":"Severe human Lassa fever is characterized by nonspecific T-cell activation and lymphocyte homing to inflamed tissues","author":"Port","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126479_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri.2016.138","article-title":"Immunobiology of Ebola and Lassa virus infections","volume":"17","author":"Prescott","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.126479_bb0110","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00951-22","article-title":"Safety and pharmacokinetics of LHF-535, a potential treatment for Lassa fever, in healthy adults","volume":"66","author":"Amberg","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2024.126479_bb0115","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.vaccine.2024.126479_bb0120","doi-asserted-by":"crossref","first-page":"19911","DOI":"10.1038\/s41598-022-23760-2","article-title":"Lassa antiviral LHF-535 protects guinea pigs from lethal challenge","volume":"12","author":"Cashman","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.126479_bb0125","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/infdis\/jiv522","article-title":"Efficacy of favipiravir alone and in combination with ribavirin in a lethal, immunocompetent mouse model of Lassa fever","volume":"213","author":"Oestereich","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0130","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/cid\/cix406","article-title":"Favipiravir and ribavirin treatment of epidemiologically linked cases of Lassa fever","volume":"65","author":"Raabe","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0135","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3201\/eid2409.180233","article-title":"Use of favipiravir to treat Lassa virus infection in macaques","volume":"24","author":"Rosenke","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0140","doi-asserted-by":"crossref","first-page":"14775","DOI":"10.1038\/srep14775","article-title":"The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset","volume":"5","author":"Safronetz","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.126479_bb0145","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/jac\/dkac064","article-title":"Contemporary and emerging pharmacotherapeutic agents for the treatment of Lassa viral haemorrhagic fever disease","volume":"77","author":"Joseph","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2024.126479_bb0150","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.vaccine.2024.126479_bb0155","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.vaccine.2024.126479_bb0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21010\/Ajidv16i2S.6","article-title":"Prospects of Lassa fever candidate vaccines","volume":"16","author":"Isaac","year":"2022","journal-title":"Afr J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0165","doi-asserted-by":"crossref","first-page":"e1011","DOI":"10.1016\/j.ijid.2013.05.015","article-title":"Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-march 2012)","volume":"17","author":"Ajayi","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2055-6640(20)30306-X","article-title":"Lassa fever outbreak in adolescents in north Central Nigeria: report of cases","volume":"4","author":"Akhiwu","year":"2018","journal-title":"J Virus Erad"},{"key":"10.1016\/j.vaccine.2024.126479_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005711","article-title":"Prevalence of Lassa virus disease (LVD) in Nigerian children with fever or fever and convulsions in an endemic area","volume":"11","author":"Akhuemokhan","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0180","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/jpids\/piy093","article-title":"Acute abdomen in pediatric patients with Lassa fever: prevalence and response to nonoperative management","volume":"8","author":"Akpede","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2024.126479_bb0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/trstmh\/tru009","article-title":"Constraints in the diagnosis and treatment of Lassa fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone","volume":"108","author":"Dahmane","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.126479_bb0190","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S2214-109X(20)30518-0","article-title":"Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study","volume":"9","author":"Duvignaud","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2024.126479_bb0195","doi-asserted-by":"crossref","first-page":"S783","DOI":"10.1093\/clinids\/11.Supplement_4.S783","article-title":"Clinical features of Lassa fever in Liberia","volume":"11","author":"Frame","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0200","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ijid.2022.07.006","article-title":"Epidemiological characteristics of Lassa fever cases in Liberia: a retrospective analysis of surveillance data, 2019-2020","volume":"122","author":"Jetoh","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0205","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1473-3099(18)30121-X","article-title":"Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study","volume":"18","author":"Okokhere","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0210","first-page":"133","article-title":"Positivity rate, predictors, and outcome of paediatric Lassa fever disease (LFD) in a Lassa fever endemic state","volume":"62","author":"Orji","year":"2021","journal-title":"South-East Nigeria Niger Med J"},{"key":"10.1016\/j.vaccine.2024.126479_bb0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0163-4453(82)91133-1","article-title":"Lassa fever in children","volume":"4","author":"Sharp","year":"1982","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2024.126479_bb0220","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0035-9203(86)90147-1","article-title":"Lassa fever in children in Sierra Leone, West Africa","volume":"80","author":"Webb","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.126479_bb0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4081\/acbr.2020.97","article-title":"Case series of outcome of newborn babies exposed to Lassa fever virus infection","volume":"1","author":"Obu","year":"2020","journal-title":"Ann Clin Biomed Res"},{"key":"10.1016\/j.vaccine.2024.126479_bb0230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40249-020-00731-1","article-title":"Fatal case of newborn Lassa fever virus infection mimicking late onset neonatal sepsis: a case report from northern Nigeria","volume":"9","author":"Ogunkunle","year":"2020","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.vaccine.2024.126479_bb0235","series-title":"The Continuous Textbook of Women\u2019s Medicine Series","article-title":"Maternal immunization (Vol. 17). Lassa fever","author":"Okogbenin","year":"2023"},{"key":"10.1016\/j.vaccine.2024.126479_bb0240","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/155.3.456","article-title":"Clinical virology of Lassa fever in hospitalized patients","volume":"155","author":"Johnson","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0245","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","article-title":"A prospective study of the epidemiology and ecology of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0250","first-page":"349","article-title":"Pathologic and virologic study of fatal Lassa fever in man","volume":"107","author":"Walker","year":"1982","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2024.126479_bb0255","first-page":"239","article-title":"Symptomatology of Lassa fever in pregnancy: key findings for standard operating procedure development","volume":"101","author":"Abejegah","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0260","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3201\/eid2508.181299","article-title":"Retrospective cohort study of Lassa fever in pregnancy","volume":"25","author":"Okogbenin","year":"2019","journal-title":"Southern Nigeria Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126479_bb0265","author":"Pan African Clinical Trial Registry"},{"key":"10.1016\/j.vaccine.2024.126479_bb0270","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.vaccine.2024.126479_bb0275","author":"Pan African Clinical Trial Registry"},{"key":"10.1016\/j.vaccine.2024.126479_bb0280","author":"Pan African Clinical Trial Registry"},{"key":"10.1016\/j.vaccine.2024.126479_bb0285","series-title":"Safety, tolerability and immunogenicity of INO-4500 in healthy volunteers","author":"ClinicalTrials.gov","year":"2024"},{"key":"10.1016\/j.vaccine.2024.126479_bb0290","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.vaccine.2024.126479_bb0295","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJMc1415318","article-title":"Ebola virus disease among children in West Africa","volume":"372","author":"Agua-Agum","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.126479_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279467","article-title":"Epidemiological trends of Lassa fever in Nigeria, 2018-2021","volume":"17","author":"Dalhat","year":"2022","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2024.126479_bb0305","doi-asserted-by":"crossref","first-page":"22330","DOI":"10.1038\/s41598-022-26045-w","article-title":"Humoral and cellular immune responses to Lassa fever virus in Lassa fever survivors and their exposed contacts in southern Nigeria","volume":"12","author":"Ugwu","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.126479_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575197","article-title":"Maternal immunological adaptation during normal pregnancy","volume":"11","author":"Abu-Raya","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126479_bb0315","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bcp.12305","article-title":"Clinical trials in children","volume":"79","author":"Joseph","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.vaccine.2024.126479_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000191","article-title":"Analysis of sociodemographic and clinical factors associated with Lassa fever disease and mortality in Nigeria","volume":"2","author":"Olayinka","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"10.1016\/j.vaccine.2024.126479_bb0325","first-page":"242","article-title":"The promise, problems, and pitfalls of including pregnant women in clinical trials of Lassa fever vaccine: a qualitative assessment of sub-Sahara Africa investigators\u2019 perception","volume":"41","author":"Salami","year":"2022","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.vaccine.2024.126479_bb0330","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1016\/j.vaccine.2021.10.048","article-title":"Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020","volume":"39","author":"Voss","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126479_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283643","article-title":"A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in west African countries (the enable Lassa research programme)-study protocol","volume":"18","author":"Penfold","year":"2023","journal-title":"PloS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24011617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24011617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T10:42:24Z","timestamp":1734000144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24011617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":67,"alternative-id":["S0264410X24011617"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126479","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burden of Lassa fever disease in pregnant women and children and options for prevention","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126479"}}